Brandon M Barney

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Increased Bowel Toxicity in Patients Treated With a Vascular Endothelial Growth Factor Inhibitor (VEGFI) After Stereotactic Body Radiation Therapy (SBRT)
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota Electronic address
    Int J Radiat Oncol Biol Phys 87:73-80. 2013
  2. doi request reprint Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Clin Oncol 35:537-42. 2012
  3. doi request reprint The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Int J Radiat Oncol Biol Phys 85:109-15. 2013
  4. pmc Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
    Radiat Oncol 7:67. 2012
  5. doi request reprint Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA
    Int J Radiat Oncol Biol Phys 83:191-7. 2012
  6. doi request reprint Intraoperative electron beam radiotherapy (IOERT) in the management of recurrent ovarian malignancies
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
    Int J Gynecol Cancer 21:1225-31. 2011
  7. doi request reprint Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT)
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 80:301-5. 2011
  8. doi request reprint Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer
    Brandon M Barney
    Mayo Clinic, Rochester, Minnesota, USA
    Head Neck 33:645-9. 2011
  9. ncbi request reprint An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer
    Brandon M Barney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, 1950 Circle of Hope, Salt Lake City, UT 84112, USA
    Brachytherapy 6:201-6. 2007
  10. pmc Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
    Kamran A Ahmed
    Department of Radiation Oncology, Moffitt Cancer Center Tampa, FL, USA
    Front Oncol 2:215. 2012

Detail Information

Publications10

  1. doi request reprint Increased Bowel Toxicity in Patients Treated With a Vascular Endothelial Growth Factor Inhibitor (VEGFI) After Stereotactic Body Radiation Therapy (SBRT)
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota Electronic address
    Int J Radiat Oncol Biol Phys 87:73-80. 2013
    ..We explored the incidence of serious bowel injury (SBI) in patients treated with SBRT with or without vascular endothelial growth factor inhibitor (VEGFI) therapy...
  2. doi request reprint Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Clin Oncol 35:537-42. 2012
    ..To present clinical outcomes, early toxicity, and dosimetric constraints for patients undergoing stereotactic body radiation therapy (SBRT) for abdominal or pelvic tumors...
  3. doi request reprint The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Int J Radiat Oncol Biol Phys 85:109-15. 2013
    ..We report on the largest single-institution experience using adjuvant high-dose-rate vaginal brachytherapy (VBT) for surgically staged women with FIGO stage I UPSC or CC endometrial cancer...
  4. pmc Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
    Radiat Oncol 7:67. 2012
    ..To report single-institutional clinical outcomes and toxicity with SBRT for cholangiocarcinoma...
  5. doi request reprint Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA
    Int J Radiat Oncol Biol Phys 83:191-7. 2012
    ..To report our institutional experience with intraoperative radiotherapy (IORT) as a component of treatment for women with locally advanced or recurrent uterine sarcoma...
  6. doi request reprint Intraoperative electron beam radiotherapy (IOERT) in the management of recurrent ovarian malignancies
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
    Int J Gynecol Cancer 21:1225-31. 2011
    ..To investigate disease control, survival outcomes, and tolerance of intraoperative electron beam radiation therapy (IOERT) as a component of treatment for women with recurrent ovarian malignancies...
  7. doi request reprint Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT)
    Brandon M Barney
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 80:301-5. 2011
    ..To present our single-institution experience with image-guided radiotherapy comparing fiducial markers and cone-beam computed tomography (CBCT) for daily localization of prostate cancer...
  8. doi request reprint Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer
    Brandon M Barney
    Mayo Clinic, Rochester, Minnesota, USA
    Head Neck 33:645-9. 2011
    ..The purpose of this study was to evaluate the type of resection, age, T classification, nodal status, tumor size, and year of diagnosis for overall survival (OS) and cause-specific survival (CSS) using a large database...
  9. ncbi request reprint An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer
    Brandon M Barney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, 1950 Circle of Hope, Salt Lake City, UT 84112, USA
    Brachytherapy 6:201-6. 2007
    ..Secondary endpoints included assessment of acute and late treatment toxicity, medication requirements, and charges related to the HDR-BT simulation and procedure...
  10. pmc Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
    Kamran A Ahmed
    Department of Radiation Oncology, Moffitt Cancer Center Tampa, FL, USA
    Front Oncol 2:215. 2012
    ..More importantly, over half the patients achieved an undetectable PSA after SBRT. Further follow-up is necessary to assess the long-term impact of SBRT on LC, toxicity, PSA response, and clinical outcomes...